Quantcast

Latest Exagen Diagnostics Inc. Stories

2010-10-12 08:00:00

ALBUQUERQUE, N.M., Oct. 12 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced the purchase of Cypress Bioscience, Inc.'s diagnostic business, located in San Diego, Calif. Under the terms of the agreement, Exagen will purchase the diagnostic business in its entirety, including all testing services, intellectual property rights and equipment. Exagen has offered employment to all Cypress...

2010-07-08 08:00:00

ALBUQUERQUE, N.M., July 8 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP). The CAP is a leading organization of board-certified pathologists that serves patients, pathologists and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine. The CAP...

2010-02-16 08:00:00

ALBUQUERQUE, N.M., Feb. 16 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced an exclusive sales and marketing agreement with EndoChoice, Inc. to promote its diagnostic services to gastroenterologists throughout the United States. Under the agreement, EndoChoice's experienced, gastroenterology-focused sales force will introduce Exagen's proprietary gene expression tests for the...

2009-12-01 08:00:00

ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced the appointment of Scott Glenn as chairman of the company's board of directors and chief executive officer. Prior to joining Exagen, Glenn was managing partner of Windamere Venture Partners and founder of a number of successful biomedical companies including Prometheus Laboratories, Santarus, Dexcom, Somaxon...

2009-05-28 08:00:00

Company signs partnership agreement with Clinical Reference Laboratory ALBUQUERQUE, N.M., May 28 /PRNewswire/ -- Exagen Diagnostics, Inc. today announced the availability of two new genomic blood tests to assist physicians with diagnosing Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). Exagen will present the tests at Digestive Disease Week 2009 in Chicago, May 30 - June 4, booth #2429. The eXaIBStest identifies patients with IBS, while the eXaIBD test identifies...

2009-02-17 08:49:00

ALBUQUERQUE, N.M., Feb. 17 /PRNewswire/ -- Exagen Diagnostics, Inc., which provides proprietary molecular diagnostics testing services, genomic probes for research and analytic specific reagents to clinical laboratories and academic institutions, today announced that John Alsobrook, Ph.D., has been named vice president and chief operating officer. In his new role, Alsobrook oversees Exagen's day-to-day operations, company alliances and genomic marker discovery and development programs. He...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.